Global Drug Screening Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 175311
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Medical Devices
Buy @ $3500

The Drug Screening market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Drug Screening size is estimated to be xx million in 2020 from USD 4208.2 million in 2019, with a change of XX% between 2019 and 2020. The global Drug Screening market size is expected to grow at a CAGR of 5.3% for the next five years.

Market segmentation

Drug Screening market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Immunoassay Analyzers

Chromatography

Breath Analyzers

Rapid Testing Devices

Assay Kits and Reagents

Market segment by Application can be divided into

Hospitals

Research Institute

Biotechnology & Pharmaceutical Companies

Other

The key market players for global Drug Screening market are listed below:

Abbott

Express Diagnostics

Laboratory Corporation of America

MPD

Quest Diagnostics

Roche Diagnostics

Shimadzu

Siemens Healthcare

Thermo Fisher Scientific

Market segment by Region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Drug Screening Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Drug Screening Revenue by Type: 2019 Versus 2021 Versus 2026

1.2.2 Immunoassay Analyzers

1.2.3 Chromatography

1.2.4 Breath Analyzers

1.2.5 Rapid Testing Devices

1.2.6 Assay Kits and Reagents

1.3 Market Analysis by Application

1.3.1 Overview: Global Drug Screening Revenue by Application: 2019 Versus 2021 Versus 2026

1.3.2 Hospitals

1.3.3 Research Institute

1.3.4 Biotechnology & Pharmaceutical Companies

1.3.5 Other

1.4 Global Drug Screening Market Size & Forecast

1.4.1 Global Drug Screening Sales in Value (2016-2026))

1.4.2 Global Drug Screening Sales in Volume (2016-2026)

1.4.3 Global Drug Screening Price by Type (2016-2026) & (USD/Unit)

1.5 Global Drug Screening Production Capacity Analysis

1.5.1 Global Drug Screening Total Production Capacity (2016-2026)

1.5.2 Global Drug Screening Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Drug Screening Market Drivers

1.6.2 Drug Screening Market Restraints

1.6.3 Drug Screening Trends Analysis

2 Manufacturers Profiles

2.1 Abbott

2.1.1 Abbott Details

2.1.2 Abbott Major Business

2.1.3 Abbott Drug Screening Product and Services

2.1.4 Abbott Drug Screening Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)

2.2 Express Diagnostics

2.2.1 Express Diagnostics Details

2.2.2 Express Diagnostics Major Business

2.2.3 Express Diagnostics Drug Screening Product and Services

2.2.4 Express Diagnostics Drug Screening Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)

2.3 Laboratory Corporation of America

2.3.1 Laboratory Corporation of America Details

2.3.2 Laboratory Corporation of America Major Business

2.3.3 Laboratory Corporation of America Drug Screening Product and Services

2.3.4 Laboratory Corporation of America Drug Screening Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)

2.4 MPD

2.4.1 MPD Details

2.4.2 MPD Major Business

2.4.3 MPD Drug Screening Product and Services

2.4.4 MPD Drug Screening Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)

2.5 Quest Diagnostics

2.5.1 Quest Diagnostics Details

2.5.2 Quest Diagnostics Major Business

2.5.3 Quest Diagnostics Drug Screening Product and Services

2.5.4 Quest Diagnostics Drug Screening Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)

2.6 Roche Diagnostics

2.6.1 Roche Diagnostics Details

2.6.2 Roche Diagnostics Major Business

2.6.3 Roche Diagnostics Drug Screening Product and Services

2.6.4 Roche Diagnostics Drug Screening Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)

2.7 Shimadzu

2.7.1 Shimadzu Details

2.7.2 Shimadzu Major Business

2.7.3 Shimadzu Drug Screening Product and Services

2.7.4 Shimadzu Drug Screening Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)

2.8 Siemens Healthcare

2.8.1 Siemens Healthcare Details

2.8.2 Siemens Healthcare Major Business

2.8.3 Siemens Healthcare Drug Screening Product and Services

2.8.4 Siemens Healthcare Drug Screening Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)

2.9 Thermo Fisher Scientific

2.9.1 Thermo Fisher Scientific Details

2.9.2 Thermo Fisher Scientific Major Business

2.9.3 Thermo Fisher Scientific Drug Screening Product and Services

2.9.4 Thermo Fisher Scientific Drug Screening Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)

3 Drug Screening Sales by Manufacturer

3.1 Global Drug Screening Sales in Volume by Manufacturer (2019-2021e)

3.2 Global Drug Screening Revenue by Manufacturer (2019-2021e)

3.3 Key Manufacturer Market Position in Drug Screening

3.4 Market Concentration Rate

3.4.1 Top 3 Drug Screening Manufacturer Market Share

3.4.2 Top 6 Drug Screening Manufacturer Market Share

3.5 Global Drug Screening Production Capacity by Company

3.6 Manufacturer by Geography: Head Office and Drug Screening Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Drug Screening Market Size by Region

4.1.1 Global Drug Screening Sales in Volume by Region (2016-2026)

4.1.2 Global Drug Screening Revenue by Region (2016-2026)

4.2 North America Drug Screening Revenue (2016-2026)

4.3 Europe Drug Screening Revenue (2016-2026)

4.4 Asia-Pacific Drug Screening Revenue (2016-2026)

4.5 South America Drug Screening Revenue (2016-2026)

4.6 Middle East and Africa Drug Screening Revenue (2016-2026)

5 Market Segment by Type

5.1 Global Drug Screening Sales in Volume by Type (2016-2026)

5.2 Global Drug Screening Revenue by Type (2016-2026)

5.3 Global Drug Screening Price by Type (2016-2026)

6 Market Segment by Application

6.1 Global Drug Screening Sales in Volume by Application (2016-2026)

6.2 Global Drug Screening Revenue by Application (2016-2026)

6.3 Global Drug Screening Price by Application (2016-2026)

7 North America by Country, by Type, and by Application

7.1 North America Drug Screening Sales by Type (2016-2026)

7.2 North America Drug Screening Sales by Application (2016-2026)

7.3 North America Drug Screening Market Size by Country

7.3.1 North America Drug Screening Sales in Volume by Country (2016-2026)

7.3.2 North America Drug Screening Revenue by Country (2016-2026)

7.3.3 United States Market Size and Forecast (2016-2026)

7.3.4 Canada Market Size and Forecast (2016-2026)

7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application

8.1 Europe Drug Screening Sales by Type (2016-2026)

8.2 Europe Drug Screening Sales by Application (2016-2026)

8.3 Europe Drug Screening Market Size by Country

8.3.1 Europe Drug Screening Sales in Volume by Country (2016-2026)

8.3.2 Europe Drug Screening Revenue by Country (2016-2026)

8.3.3 Germany Market Size and Forecast (2016-2026)

8.3.4 France Market Size and Forecast (2016-2026)

8.3.5 United Kingdom Market Size and Forecast (2016-2026)

8.3.6 Russia Market Size and Forecast (2016-2026)

8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application

9.1 Asia-Pacific Drug Screening Sales by Type (2016-2026)

9.2 Asia-Pacific Drug Screening Sales by Application (2016-2026)

9.3 Asia-Pacific Drug Screening Market Size by Region

9.3.1 Asia-Pacific Drug Screening Sales in Volume by Region (2016-2026)

9.3.2 Asia-Pacific Drug Screening Revenue by Region (2016-2026)

9.3.3 China Market Size and Forecast (2016-2026)

9.3.4 Japan Market Size and Forecast (2016-2026)

9.3.5 Korea Market Size and Forecast (2016-2026)

9.3.6 India Market Size and Forecast (2016-2026)

9.3.7 Southeast Asia Market Size and Forecast (2016-2026)

9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application

10.1 South America Drug Screening Sales by Type (2016-2026)

10.2 South America Drug Screening Sales by Application (2016-2026)

10.3 South America Drug Screening Market Size by Country

10.3.1 South America Drug Screening Sales in Volume by Country (2016-2026)

10.3.2 South America Drug Screening Revenue by Country (2016-2026)

10.3.3 Brazil Market Size and Forecast (2016-2026)

10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Drug Screening Sales by Type (2016-2026)

11.2 Middle East & Africa Drug Screening Sales by Application (2016-2026)

11.3 Middle East & Africa Drug Screening Market Size by Country

11.3.1 Middle East & Africa Drug Screening Sales in Volume by Country (2016-2026)

11.3.2 Middle East & Africa Drug Screening Revenue by Country (2016-2026)

11.3.3 Turkey Market Size and Forecast (2016-2026)

11.3.4 Egypt Market Size and Forecast (2016-2026)

11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)

11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Drug Screening Typical Distributors

12.3 Drug Screening Typical Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Drug Screening Revenue by Type, (USD Million), 2021-2026

Table 2. Global Drug Screening Revenue by Application, (USD Million), 2021-2026

Table 3. Abbott Basic Information, Manufacturing Base and Competitors

Table 4. Abbott Major Business

Table 5. Abbott Drug Screening Product and Services

Table 6. Abbott Drug Screening Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 7. Express Diagnostics Basic Information, Manufacturing Base and Competitors

Table 8. Express Diagnostics Major Business

Table 9. Express Diagnostics Drug Screening Product and Services

Table 10. Express Diagnostics Drug Screening Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 11. Laboratory Corporation of America Basic Information, Manufacturing Base and Competitors

Table 12. Laboratory Corporation of America Major Business

Table 13. Laboratory Corporation of America Drug Screening Product and Services

Table 14. Laboratory Corporation of America Drug Screening Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 15. MPD Basic Information, Manufacturing Base and Competitors

Table 16. MPD Major Business

Table 17. MPD Drug Screening Product and Services

Table 18. MPD Drug Screening Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 19. Quest Diagnostics Basic Information, Manufacturing Base and Competitors

Table 20. Quest Diagnostics Major Business

Table 21. Quest Diagnostics Drug Screening Product and Services

Table 22. Quest Diagnostics Drug Screening Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 23. Roche Diagnostics Basic Information, Manufacturing Base and Competitors

Table 24. Roche Diagnostics Major Business

Table 25. Roche Diagnostics Drug Screening Product and Services

Table 26. Roche Diagnostics Drug Screening Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 27. Shimadzu Basic Information, Manufacturing Base and Competitors

Table 28. Shimadzu Major Business

Table 29. Shimadzu Drug Screening Product and Services

Table 30. Shimadzu Drug Screening Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 31. Siemens Healthcare Basic Information, Manufacturing Base and Competitors

Table 32. Siemens Healthcare Major Business

Table 33. Siemens Healthcare Drug Screening Product and Services

Table 34. Siemens Healthcare Drug Screening Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 35. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors

Table 36. Thermo Fisher Scientific Major Business

Table 37. Thermo Fisher Scientific Drug Screening Product and Services

Table 38. Thermo Fisher Scientific Drug Screening Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 39. Global Drug Screening Sales by Manufacturer (2019-2021e) & (K Units)

Table 40. Global Drug Screening Revenue by Manufacturer (2019-2021e) & (USD Million)

Table 41. Market Position of Manufacturers in Drug Screening, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020

Table 42. Global Drug Screening Production Capacity by Company, (K Units): 2020 VS 2021

Table 43. Head Office and Drug Screening Production Site of Key Manufacturer

Table 44. Global Drug Screening Sales by Region (2016-2021e) & (K Units)

Table 45. Global Drug Screening Sales by Region (2021-2026) & (K Units)

Table 46. Global Drug Screening Revenue by Region (2016-2021e) & (USD Million)

Table 47. Global Drug Screening Revenue by Region (2021-2026) & (USD Million)

Table 48. Global Drug Screening Sales by Type (2016-2021e) & (K Units)

Table 49. Global Drug Screening Sales by Type (2021-2026) & (K Units)

Table 50. Global Drug Screening Revenue by Type (2016-2021e) & (USD Million)

Table 51. Global Drug Screening Revenue by Type (2021-2026) & (USD Million)

Table 52. Global Drug Screening Price by Type (2016-2021e) & (USD/Unit)

Table 53. Global Drug Screening Price by Type (2021-2026) & (USD/Unit)

Table 54. Global Drug Screening Sales by Application (2016-2021e) & (K Units)

Table 55. Global Drug Screening Sales by Application (2021-2026) & (K Units)

Table 56. Global Drug Screening Revenue by Application (2016-2021e) & (USD Million)

Table 57. Global Drug Screening Revenue by Application (2021-2026) & (USD Million)

Table 58. Global Drug Screening Price by Application (2016-2021e) & (USD/Unit)

Table 59. Global Drug Screening Price by Application (2021-2026) & (USD/Unit)

Table 60. North America Drug Screening Sales by Country (2016-2021e) & (K Units)

Table 61. North America Drug Screening Sales by Country (2021-2026) & (K Units)

Table 62. North America Drug Screening Revenue by Country (2016-2021e) & (USD Million)

Table 63. North America Drug Screening Revenue by Country (2021-2026) & (USD Million)

Table 64. North America Drug Screening Sales by Type (2016-2021e) & (K Units)

Table 65. North America Drug Screening Sales by Type (2021-2026) & (K Units)

Table 66. North America Drug Screening Sales by Application (2016-2021e) & (K Units)

Table 67. North America Drug Screening Sales by Application (2021-2026) & (K Units)

Table 68. Europe Drug Screening Sales by Country (2016-2021e) & (K Units)

Table 69. Europe Drug Screening Sales by Country (2021-2026) & (K Units)

Table 70. Europe Drug Screening Revenue by Country (2016-2021e) & (USD Million)

Table 71. Europe Drug Screening Revenue by Country (2021-2026) & (USD Million)

Table 72. Europe Drug Screening Sales by Type (2016-2021e) & (K Units)

Table 73. Europe Drug Screening Sales by Type (2021-2026) & (K Units)

Table 74. Europe Drug Screening Sales by Application (2016-2021e) & (K Units)

Table 75. Europe Drug Screening Sales by Application (2021-2026) & (K Units)

Table 76. Asia-Pacific Drug Screening Sales by Region (2016-2021e) & (K Units)

Table 77. Asia-Pacific Drug Screening Sales by Region (2021-2026) & (K Units)

Table 78. Asia-Pacific Drug Screening Revenue by Region (2016-2021e) & (USD Million)

Table 79. Asia-Pacific Drug Screening Revenue by Region (2021-2026) & (USD Million)

Table 80. Asia-Pacific Drug Screening Sales by Type (2016-2021e) & (K Units)

Table 81. Asia-Pacific Drug Screening Sales by Type (2021-2026) & (K Units)

Table 82. Asia-Pacific Drug Screening Sales by Application (2016-2021e) & (K Units)

Table 83. Asia-Pacific Drug Screening Sales by Application (2021-2026) & (K Units)

Table 84. South America Drug Screening Sales by Country (2016-2021e) & (K Units)

Table 85. South America Drug Screening Sales by Country (2021-2026) & (K Units)

Table 86. South America Drug Screening Revenue by Country (2016-2021e) & (USD Million)

Table 87. South America Drug Screening Revenue by Country (2021-2026) & (USD Million)

Table 88. South America Drug Screening Sales by Type (2016-2021e) & (K Units)

Table 89. South America Drug Screening Sales by Type (2021-2026) & (K Units)

Table 90. South America Drug Screening Sales by Application (2016-2021e) & (K Units)

Table 91. South America Drug Screening Sales by Application (2021-2026) & (K Units)

Table 92. Middle East & Africa Drug Screening Sales by Country (2016-2021e) & (K Units)

Table 93. Middle East & Africa Drug Screening Sales by Country (2021-2026) & (K Units)

Table 94. Middle East & Africa Drug Screening Revenue by Country (2016-2021e) & (USD Million)

Table 95. Middle East & Africa Drug Screening Revenue by Country (2021-2026) & (USD Million)

Table 96. Middle East & Africa Drug Screening Sales by Type (2016-2021e) & (K Units)

Table 97. Middle East & Africa Drug Screening Sales by Type (2021-2026) & (K Units)

Table 98. Middle East & Africa Drug Screening Sales by Application (2016-2021e) & (K Units)

Table 99. Middle East & Africa Drug Screening Sales by Application (2021-2026) & (K Units)

Table 100. Direct Channel Pros & Cons

Table 101. Indirect Channel Pros & Cons

Table 102. Drug Screening Typical Distributors

Table 103. Drug Screening Typical Customers

List of Figures

Figure 1. Drug Screening Picture

Figure 2. Global Drug Screening Sales Market Share by Type in 2020

Figure 3. Immunoassay Analyzers

Figure 4. Chromatography

Figure 5. Breath Analyzers

Figure 6. Rapid Testing Devices

Figure 7. Assay Kits and Reagents

Figure 8. Global Drug Screening Sales Market Share by Application in 2020

Figure 9. Hospitals

Figure 10. Research Institute

Figure 11. Biotechnology & Pharmaceutical Companies

Figure 12. Other

Figure 13. Global Drug Screening Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026

Figure 14. Global Drug Screening Market Size and Forecast (2016-2026) & (USD Million)

Figure 15. United States Drug Screening Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 16. Canada Drug Screening Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 17. Mexico Drug Screening Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 18. Germany Drug Screening Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 19. France Drug Screening Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 20. United Kingdom Drug Screening Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 21. Russia Drug Screening Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 22. Italy Drug Screening Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 23. China Drug Screening Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 24. Japan Drug Screening Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 25. Korea Drug Screening Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 26. India Drug Screening Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 27. Southeast Asia Drug Screening Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 28. Australia Drug Screening Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 29. Brazil Drug Screening Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 30. Egypt Drug Screening Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 31. Saudi Arabia Drug Screening Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 32. South Africa Drug Screening Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 33. Turkey Drug Screening Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 34. Global Drug Screening Sales (2016-2026) & (K Units)

Figure 35. Global Drug Screening Production Capacity (2016-2026) & (K Units)

Figure 36. Global Drug Screening Production Capacity by Geographic Region: 2020 VS 2021

Figure 37. Drug Screening Market Drivers

Figure 38. Drug Screening Market Restraints

Figure 39. Drug Screening Market Trends

Figure 40. Global Drug Screening Sales Market Share by Manufacturer in 2020

Figure 41. Global Drug Screening Revenue Market Share by Manufacturer in 2020

Figure 42. Drug Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 43. Top 3 Drug Screening Manufacturer (Revenue) Market Share in 2020

Figure 44. Top 6 Drug Screening Manufacturer (Revenue) Market Share in 2020

Figure 45. Global Drug Screening Sales Market Share by Region (2016-2026)

Figure 46. Global Drug Screening Revenue Market Share by Region (2016-2026)

Figure 47. North America Drug Screening Revenue (2016-2026) & (USD Million)

Figure 48. Europe Drug Screening Revenue (2016-2026) & (USD Million)

Figure 49. Asia-Pacific Drug Screening Revenue (2016-2026) & (USD Million)

Figure 50. South America Drug Screening Revenue (2016-2026) & (USD Million)

Figure 51. Middle East & Africa Drug Screening Revenue (2016-2026) & (USD Million)

Figure 52. Global Drug Screening Sales Market Share by Type (2016-2026)

Figure 53. Global Drug Screening Revenue Market Share by Type (2016-2026)

Figure 54. Global Drug Screening Price by Type (2016-2026) & (USD/Unit)

Figure 55. Global Drug Screening Sales Market Share by Application (2016-2026)

Figure 56. Global Drug Screening Revenue Market Share by Application (2016-2026)

Figure 57. Global Drug Screening Price by Application (2016-2026) & (USD/Unit)

Figure 58. North America Drug Screening Sales Market Share by Country (2016-2026)

Figure 59. North America Drug Screening Revenue Market Share by Country (2016-2026)

Figure 60. North America Drug Screening Sales Market Share by Type (2016-2026)

Figure 61. North America Drug Screening Sales Market Share by Application (2016-2026)

Figure 62. Europe Drug Screening Sales Market Share by Country (2016-2026)

Figure 63. Europe Drug Screening Revenue Market Share by Country (2016-2026)

Figure 64. Europe Drug Screening Sales Market Share by Type (2016-2026)

Figure 65. Europe Drug Screening Sales Market Share by Application (2016-2026)

Figure 66. Asia-Pacific Drug Screening Sales Market Share by Region (2016-2026)

Figure 67. Asia-Pacific Drug Screening Revenue Market Share by Region (2016-2026)

Figure 68. Asia-Pacific Drug Screening Sales Market Share by Region (2016-2026)

Figure 69. Asia-Pacific Drug Screening Sales Market Share by Application (2016-2026)

Figure 70. South America Drug Screening Sales Market Share by Country (2016-2026)

Figure 71. South America Drug Screening Revenue Market Share by Country (2016-2026)

Figure 72. South America Drug Screening Sales Market Share by Type (2016-2026)

Figure 73. South America Drug Screening Sales Market Share by Application (2016-2026)

Figure 74. Middle East & Africa Drug Screening Sales Market Share by Country (2016-2026)

Figure 75. Middle East & Africa Drug Screening Revenue Market Share by Country (2016-2026)

Figure 76. Middle East & Africa Drug Screening Sales Market Share by Type (2016-2026)

Figure 77. Middle East & Africa Drug Screening Sales Market Share by Application (2016-2026)

Figure 78. Sales Channel: Direct Channel vs Indirect Channel

Figure 79. Methodology

Figure 80. Research Process and Data Source